CorMedix (CRMD +6.7%) takes a step towards achieving compliance with European regulatory requirements, saying that it's successfully passed the ISO 13485:2003 certification. The ISO 13485 is a globally recognized standard that outlines consistent international processes for the design and manufacturing of medical devices. The company anticipates a final review and determination of its CE Mark application by the end of Q4.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs